the prosaposin sequence has neurotrophic activity in vitro and in vivo. J Neurochem 66:2197–2200.
Misasi R, Sorice M, Garofalo T, Griggi T, Campana WM, Giammatteo M, Pavan A,
Hiraiwa M, Pontieri GM and O'Brien JS (1998) Colocalization and complex
formation between prosaposin and monosialoganglioside GM3 in neural cells.
J Neurochem 71:2313–2321.
O'Brien JS, Carson GS, Seo H-C, Hiraiwa M and Kishimoto Y (1994) Identification
of prosaposin as a neurotrophic factor. Proc Natl Acad Sci 91:9539 –9596.
O'Brien JS, Carson GS, Seo H-C, Hiraiwa M, Weiler S, Tomich JM, Barranger JA,
Kahn M, Azuma N and Kishimoto Y (1995) Identification of the neurotrophic factor
sequence of prosaposin. FASEB J 9:681– 685.
Pardridge WM (1991) Peptide Drug Delivery to the Brain. Raven Press, New York.
Patlak CS, Blasberg RG and Fenstermacher JD (1983) Graphical evaluation of
blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood
Flow Metab 3:1–7.
Qi X, Kondoh K, Krusling D, Kelso GJ, Leonova T and Grabowski GA (1999)
Conformational and amino acid residue requirements for the saposin C neuritogenic effect. Biochemistry 56:6284 – 6291.
Qi X, Qin W, Sun Y, Kondoh K and Grabowski GA (1996) Functional organization of
